Article Text

PDF

Further hearing loss during osteoporosis treatment with etidronate.
  1. S. Yaşil,
  2. A. Cömlekçi,
  3. A. Güneri
  1. Dokuz Eylül University, Medical Faculty, Inciralti, Izmir, Turkey.

    Abstract

    Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.